Alexia Frapsauce
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexia Frapsauce has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Clément Delage
Université Paris Cité, Inserm, Optimisation Thérapeutique en Neuropsychopharmacologie, F-75006 Paris, France; Service de Pharmacie, AP-HP, Hôpital Lariboisière-Fernand Widal, F-75010 Paris, France
1 shared publication - Dorian Rollet
APHP GHU Nord, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 75010 Paris, France
1 shared publication - Eric Hispard
APHP GHU Nord, Site Lariboisière Fernand-Widal, Département de Psychiatrie et de Médecine Addictologique, 75010 Paris, France
1 shared publication - Florence Vorspan
Département de Psychiatrie et de Médecine Addictologique, DMU Neurosciences, GHU APHP. Nord, Assistance Publique – Hôpitaux de Paris (AP-HP)
1 shared publication - Frank Bellivier
Fondation Fondamental Créteil France
1 shared publication - Frank Questel
Département de Psychiatrie et de Médecine Addictologique, Site Lariboisière Fernand-Widal, GHU APHP Nord–Université Paris Cité, APHP, F-75010 Paris, France
1 shared publication
Latest Publications
- Open Access
- 26 November 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (12) , 1892
Ascorbic Acid Deficiency Prevalence and Associated Cognitive Impairment in Alcohol Detoxification Inpatients: A Pilot Study
Malnutrition has been reported in alcohol use disorder patients as having a possible influence on cognitive function. The aim of this study was to analyse the prevalence of ascorbic acid (AA) deficiency in inpatients admitted for alcohol detoxification and the associated factors, including cognitive impairment in the early period of abstinence. A retrospective chart review was conducted. The AA level was categorised into three groups: deficiency (AAD) (p = 0.037) and sedative use disorder (β = −2.77, p = 0.046) were associated with the MoCA score. AAD and AAI are frequent in inpatients admitted for alcohol detoxification. A low level of AA was associated with cognitive impairment in the early period of abstinence.
- 26 November 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (12) , 1892
Open AccessAscorbic Acid Deficiency Prevalence and Associated Cognitive Impairment in Alcohol Detoxification Inpatients: A Pilot Study
Malnutrition has been reported in alcohol use disorder patients as having a possible influence on cognitive function. The aim of this study was to analyse the prevalence of ascorbic acid (AA) deficiency in inpatients admitted for alcohol detoxification and the associated factors, including cognitive impairment in the early period of abstinence. A retrospective chart review was conducted. The AA level was categorised into three groups: deficiency (AAD) (p = 0.037) and sedative use disorder (β = −2.77, p = 0.046) were associated with the MoCA score. AAD and AAI are frequent in inpatients admitted for alcohol detoxification. A low level of AA was associated with cognitive impairment in the early period of abstinence.